These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7490247)

  • 1. Multidrug drug resistance in pediatric sarcomas.
    Chan HS; DeBoer G; Haddad G; Ling V
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):889-908. PubMed ID: 7490247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance in pediatric malignancies.
    Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance. Clinical opportunities in diagnosis and circumvention.
    Chan HS; DeBoer G; Thorner PS; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):383-410. PubMed ID: 7913705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
    Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
    Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
    Bramwell VH; Morris D; Ernst DS; Hings I; Blackstein M; Venner PM; Ette EI; Harding MW; Waxman A; Demetri GD
    Clin Cancer Res; 2002 Feb; 8(2):383-93. PubMed ID: 11839653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of P-glycoprotein expression in childhood malignant tumors.
    Kucerová H; Sumerauer D; Drahokoupilová E; Pisková M; Bedrnícek J; Eckschlager T
    Neoplasma; 2001; 48(6):472-8. PubMed ID: 11949840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies with modulators of multidrug resistance.
    Fisher GA; Sikic BI
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):363-82. PubMed ID: 7642468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance and malignancy in human osteosarcoma.
    Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
    Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
    Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulators of multidrug resistance. Preclinical studies.
    Ford JM
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):337-61. PubMed ID: 7642467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for pediatric soft-tissue sarcomas.
    Casanova M; Ferrari A
    Expert Opin Pharmacother; 2011 Mar; 12(4):517-31. PubMed ID: 21306288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance of testis cancers: the study of clinical relevance of P-glycoprotein expression.
    Eid H; Bodrogi I; Csókay B; Oláh E; Bak M
    Anticancer Res; 1996; 16(6B):3447-52. PubMed ID: 9042205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
    Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
    Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
    Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
    Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chemotherapy in pediatric nonrhabdomyosarcoma soft-tissue sarcomas.
    Ferrari A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):929-38. PubMed ID: 18533802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.